|
|
||||||||
From the Center for Health Sciences (Drs. Swan and Carmelli), SRI International, Menlo Park, CA; the Department of Neurology (Dr. DeCarli), University of Kansas Medical Center, Kansas City; the University of California (Dr. Miller), San Francisco, CA; the Department of Medical & Molecular Genetics (Dr. Reed), Indiana University School of Medicine, Indianapolis; and the Boston University Medical Center (Dr. Wolf), MA.
Address correspondence and reprint requests to Dr. Gary E. Swan, Center for Health Sciences, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025.
OBJECTIVE: To characterize the risk factors and neuropsychological performance of two subgroups of community-dwelling, white elderly men free of severe cognitive impairment (n = 383; mean age, 72.9 ± 3.0 years) who differ on volumetric measurements of total brain parenchyma and white matter hyperintensity (WMH) volumes.
METHODS: Group comparisons were made of cerebrovascular disease risk factors measured at the time of imaging and at three prior examinations extending over 25 years of adult life. Measures of verbal memory and speed psychomotor processing at the time of imaging and 10 years before imaging were also available.
RESULTS: Compared with those in the "nonatrophy" group, individuals in the subgroup with "atrophy" (defined by low total brain volume and high WMH volume) were older, reported a higher level of depressive symptomatology, experienced a steeper decline in diastolic blood pressure (DBP) and a steeper increase in pulse pressure, were less physically active, had smoked for more years, and had a higher prevalence of several cardiovascular disease indicators, including an ankle/arm systolic blood pressure ratio less than 0.9, and hypertension. After multivariate analysis, the 25-year decline in DBP, the number of years smoked, and an ankle/arm index of less than 0.9 remained significant discriminators of the two groups. Lower levels of speeded performance at the time of imaging and a steeper 10-year decline in cognitive performance on selected tests were also observed in the atrophic group.
CONCLUSION: Community-dwelling older adults with volumetric brain measurements associated with accelerated aging are distinguishable on the basis of several health-related characteristics. These individuals also perform less well on certain tasks involving executive functioning.
Key words: MRIAgingWhite matter hyperintensitiesAtrophyNeuropsychological function.
This article has been cited by other articles:
![]() |
R. H. Swartz, D. T. Stuss, F. Gao, and S. E. Black Independent Cognitive Effects of Atrophy and Diffuse Subcortical and Thalamico-Cortical Cerebrovascular Disease in Dementia Stroke, March 1, 2008; 39(3): 822 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Stewart, B. S. Schwartz, C. Davatzikos, D. Shen, D. Liu, X. Wu, A. C. Todd, W. Shi, S. Bassett, and D. Youssem Past adult lead exposure is linked to neurodegeneration measured by brain MRI Neurology, May 23, 2006; 66(10): 1476 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Reitz, J. A. Luchsinger, M.-X. Tang, J. Manly, and R. Mayeux Stroke and memory performance in elderly persons without dementia. Arch Neurol, April 1, 2006; 63(4): 571 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Silvestrini, P. Pasqualetti, R. Baruffaldi, M. Bartolini, Y. Handouk, M. Matteis, F. Moffa, L. Provinciali, and F. Vernieri Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease Stroke, April 1, 2006; 37(4): 1010 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Au, J. M. Massaro, P. A. Wolf, M. E. Young, A. Beiser, S. Seshadri, R. B. D'Agostino, and C. DeCarli Association of White Matter Hyperintensity Volume With Decreased Cognitive Functioning: The Framingham Heart Study Arch Neurol, February 1, 2006; 63(2): 246 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Mangiafico, F. Sarnataro, M. Mangiafico, and C. E. Fiore Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels Age Ageing, January 1, 2006; 35(1): 60 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Prins, E. J. van Dijk, T. den Heijer, S. E. Vermeer, J. Jolles, P. J. Koudstaal, A. Hofman, and M. M. B. Breteler Cerebral small-vessel disease and decline in information processing speed, executive function and memory Brain, September 1, 2005; 128(9): 2034 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gustafson, L. Lissner, C. Bengtsson, C. Bjorkelund, and I. Skoog A 24-year follow-up of body mass index and cerebral atrophy Neurology, November 23, 2004; 63(10): 1876 - 1881. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Wiseman, B. K. Saxby, E. J. Burton, R. Barber, G. A. Ford, and J. T. O'Brien Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects Neurology, November 23, 2004; 63(10): 1892 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Seshadri, P. A. Wolf, A. Beiser, M. F. Elias, R. Au, C. S. Kase, R. B. D'Agostino, and C. DeCarli Stroke risk profile, brain volume, and cognitive function: The Framingham Offspring Study Neurology, November 9, 2004; 63(9): 1591 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Razani, K. Boone, I. Lesser, and D. Weiss Effects of Cigarette Smoking History on Cognitive Functioning in Healthy Older Adults Am J Geriatr Psychiatry, August 1, 2004; 12(4): 404 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. DeCarli, D. Mungas, D. Harvey, B. Reed, M. Weiner, H. Chui, and W. Jagust Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia Neurology, July 27, 2004; 63(2): 220 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Atwood, P. A. Wolf, N. L. Heard-Costa, J. M. Massaro, A. Beiser, R. B. D'Agostino, and C. DeCarli Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study Stroke, July 1, 2004; 35(7): 1609 - 1613. [Abstract] [Full Text] [PDF] |
||||
![]() |
A A Capizzano, L Acion, T Bekinschtein, M Furman, H Gomila, A Martinez, R Mizrahi, and S E Starkstein White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(6): 822 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Elias, L. M. Sullivan, R. B. D'Agostino, P. K. Elias, A. Beiser, R. Au, S. Seshadri, C. DeCarli, and P. A. Wolf Framingham Stroke Risk Profile and Lowered Cognitive Performance Stroke, February 1, 2004; 35(2): 404 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Wong, T. H. Mosley Jr., R. Klein, B. E.K. Klein, A. R. Sharrett, D. J. Couper, and L. D. Hubbard Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people Neurology, September 23, 2003; 61(6): 806 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
R J L Walters, N C Fox, J M Schott, W R Crum, J M Stevens, M N Rossor, and D J Thomas Transient ischaemic attacks are associated with increased rates of global cerebral atrophy J. Neurol. Neurosurg. Psychiatry, February 1, 2003; 74(2): 213 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Campbell III and C. E. Coffey Neuropsychiatric Significance of Subcortical Hyperintensity J Neuropsychiatry Clin Neurosci, May 1, 2001; 13(2): 261 - 288. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |